Skip to main content
Premium Trial:

Request an Annual Quote

UK Launches $16M Small Business Initiative to Advance Genomic Analysis Tools

NEW YORK (GenomeWeb News) – The UK government and Genomics England are collaborating to award £10 million ($16.4 million) to small businesses seeking to develop genomic analysis technologies, the Department of Health said yesterday.

The competitive funding call, which will be funded by the Department of Health and managed by Genomics England, will award up to £2 million to fund phase 1 Small Business Research Initiative projects and the remainder will be used to support phase II projects.

For phase I efforts, the partners plan to provide grants of up to £200,000 for six-month projects, and only those that complete this phase will be eligible for phase II funding, which is generally used to develop and evaluate prototypes or demonstration units.

Genomics England is a government-owned company that launched this summer with the aim of running the 100K Genomes Project, a large-scale, five-year effort to sequence and analyze 100,000 patients, or infections in patients.

The Department of Health said this funding call will run alongside the 100K Genomes Project, and the technologies the small businesses advance will help support the project partners in reaching their goals.

The competition opened yesterday.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.